ILK (65.1) Antibody sc-20019 from Santa Cruz Biotechnology, Inc.

Product Specs
ItemILK (65.1) Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $316.00Supplier Page View Company Product Page
Catalog Numbersc-20019
Reactivitymouse, rat, human
Clone65.1
Conjugate/TagUnconjugated
Hostmouse
ClonalityMonoclonal
ApplicationsWB, ELISA, IF, IHC-p, IP
TargetILK -1
IsotypeIgG2b
NCBI Full Gene Nameintegrin linked kinase
FormatPurified
Quantity200 µg/ml
NCBI Gene AliasesILK-1, ILK-2, p59ILK, ESTM24, P59, HEL-S-28
Antibody TypePrimary Antibodies

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Hypoxia restores the acidosis-induced inhibition of cancer cell disseminationCell ReportsFebruary 24, 2026Se Jong Lee, Alice Amitrano, Qinling Yuan, Debanik Choudhury, Konstantin Stoletov, Bhawana Agarwal, Avery Tran, Inês Godet, James McCann, Ryan Huizar, et al.(1:50; sc-136239, Santa Cruz), anti-ezrin (1:300; 3145, Cell Signaling Technology), anti-ILK (1:200; sc-20019, Santa Cruz or ab217025, Abcam), anti-β1-integrin (1:50; ITGB1 AIIB2, Developmental Studies Hybridoma

(2) Extracellular fluid viscosity regulates human mesenchymal stem cell lineage and functionScience advancesJanuary 3, 2025Amitrano A, Yuan Q, Agarwal B, Sen A, Dance YW, Zuo Y, Phillip JM, Gu L, Konstantopoulos K.glyceraldehyde phosphate dehydrogenase (14C10) (1:4000; 2118, Cell Signaling), and anti-ILK (1:200; sc-20019, Santa Cruz Biotechnology). Next, membranes were washed five times with 1× Tris-buffered saline with

(3) RNF19A inhibits bladder cancer progression by regulating ILK ubiquitination and inactivating the AKT/mTOR signalling pathwayBiology DirectNovember 6, 2024Hao Deng, Guanghai Ji, Jun Ma, Jun Cai, Shaoping Cheng, Fan Chengantibodies were used: anti-RNF19A (1:200; Cat: NBP1-87989; Novus Biologicals), anti-ILK (1:100; Cat: sc-20019; Santa Cruz Biotechnology), anti-Ki-67 (1:200; Cat: #9027; Cell Signaling Technology), anti-p-AKT (1:200;

(4) Inhibition of the ILK-AKT pathway by upregulation of PARVB contributes to the cochlear cell death in Fascin2 gene knockout miceCell Death DiscoveryFebruary 19, 2024Rongrong Liu, Wenjing Shang, Yingying Liu, Yi Xie, Jun Luan, Ting Zhang, Ying Ma, Zengxian Wang, Yan Sun, Xicheng Song, et al.(Proteintech, 10176-2-AP), anti-p-AKT (Cell Signaling Technology, #4060 S), anti-ILK (Santa Cruz Biotechnology, sc-20019), anti-ILK (Proteintech, 12955-1-AP), anti-p-ILK (Bioss, bs-5444R), anti-Caspase9 (Cell Signaling Technology,

(5) Dynamic roles of neutrophil extracellular traps in cancer cell adhesion and activation of Notch 1-mediated epithelial-to-mesenchymal transition in EGFR-driven lung cancer cellsFrontiers in immunologyJanuary 1, 2024Dimitrov J, Maddalena M, Terlizzi C, Altobelli GG, Pellegrino S, Mehmood T, De Rosa V, Iommelli F, Del Vecchio S.Millipore Cat# AB1076, RRID: AB_10807157), ILK (mouse monoclonal; 1:500; Santa Cruz Biotechnology Cat# sc-20019, RRID: AB_627807), CDC42 (rabbit polyclonal, 1:1000; Millipore Cat# 07-1466, RRID: AB_1977123) SNAI1

(6) The Role of Hippo Signaling Pathway and ILK in the Pathophysiology of Human Hypertrophic Scars and Keloids: An Immunohistochemical InvestigationCellsOctober 29, 2022Petrou IG, Nikou S, Madduri S, Nifora M, Bravou V, Kalbermatten DF.polyclonal,1:800,#PA5-117765,"Thermo Fisher Scientific(Waltham, MA, USA)" ILK,Mouse monoclonal,1:50,(65.1)sc-20019,"Santa Cruz Biotechnology(Santa Cruz, CA, USA)" Antibodies used in immunohistochemistry.

(7) Adherens junctions stimulate and spatially guide integrin activation and extracellular matrix depositionCell reportsJuly 19, 2022Hadjisavva R, Anastasiou O, Ioannou PS, Zheltkova M, Skourides PA.

(8) Protein interactome and cell-type expression analyses reveal that cytoplasmic FMR1-interacting protein 1 (CYFIP1), but not CYFIP2, associates with astrocytic focal adhesionJournal of neurochemistryJuly 1, 2022Ma R, Pang K, Kang H, Zhang Y, Bang G, Park S, Hwang E, Ryu JR, Kwon Y, Kang HR, et al.

(9) Suppression of SMOC2 alleviates myocardial fibrosis via the ILK/p38 pathwayFrontiers in cardiovascular medicineJanuary 1, 2022Rui H, Zhao F, Yuhua L, Hong J.prepared in DD water. The SMOC2 (SC-376104, 1:500 for western blot and 1:100 for satining) and ILK (SC-20019, 1:500) antibodies were obtained from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA). Antibodies

(10) β-elemene alleviates airway stenosis via the ILK/Akt pathway modulated by MIR143HG sponging miR-1275Cellular & molecular biology lettersJune 12, 2021Zhang G, Xue C, Zeng Y.for Western blotting of the tissue protein were: Mouse anti-ILK (1:500, Santa Cruz Biotechnology, Cat# sc-20019 RRID: AB_627807), Mouse anti-Akt (1:1000, Cell Signaling Technology, Cat#2920 RRID: AB_1147620), Mouse

(11) MicroRNA-185 inhibits the proliferation and migration of HaCaT keratinocytes by targeting peroxisome proliferator-activated receptor βExperimental and therapeutic medicineApril 1, 2021Yang J, Deng P, Qi Y, Feng X, Wen H, Chen F.cat. no. sc-10737), PPARβ (1:5,000; cat. no. sc-74440), integrin-linked kinase (ILK; 1:2,000; cat. no. sc-20019) (all from Santa Cruz Biotechnology, Inc.), phosphoinositide-dependent protein kinase 1 (PDK1, 1:2,000;

(12) POSTN promotes proliferation and epithelial-mesenchymal transition in renal cell carcinoma through ILK/AKT/mTOR pathwayJournal of CancerJanuary 1, 2021Jia YY, Yu Y, Li HJ.

(13) Monocyte Chemoattractant Protein 1 Promotes VEGF-A Expression in OSCC by Activating ILK and MEK1/2 Signaling and Downregulating miR-29cFrontiers in oncologyJanuary 1, 2020Lien MY, Chang AC, Tsai HC, Tsai MH, Hua CH, Cheng SP, Wang SW, Tang CH.VEGF-A (Santa Cruz sc7269), b-actin (Santa sc-47778), MCP-1 (Santa Cruz sc-32771), ILK (Santa Cruz sc-20019), p-MEK1/2 (Santa Cruz sc-271914), MEK1/ 2 (Santa Cruz sc-6250), p-ERK1/2 (Santa Cruz sc-7383), and

(14) BMPR2 acts as a gatekeeper to protect endothelial cells from increased TGFβ responses and altered cell mechanicsPLoS biologyDecember 1, 2019Hiepen C, Jatzlau J, Hildebrandt S, Kampfrath B, Goktas M, Murgai A, Cuellar Camacho JL, Haag R, Ruppert C, Sengle G, et al.

(15) MicroR-542-3p can mediate ILK and further inhibit cell proliferation, migration and invasion in osteosarcoma cellsAgingJanuary 11, 2019Cai W, Xu Y, Zuo W, Su Z.mILK at indoor temperature for 1h and cultured overnight with primary antibodies at 4°C (anti-ILK, sc-20019, 1:500, Santa Cruz Biotechnology, CA, USA; anti-GAPDH, ab181603, 1:10000, Abcam, MA, USA). Flushed with

(16) FPS-ZM1 and valsartan combination protects better against glomerular filtration barrier damage in streptozotocin-induced diabetic ratsJournal of physiology and biochemistryAugust 1, 2018Sanajou D, Ghorbani Haghjo A, Argani H, Roshangar L, Ahmad SNS, Jigheh ZA, Aslani S, Panah F, Rashedi J, Mesgari Abbasi M.

(17) ILK promotes angiogenic activity of mesenchymal stem cells in multiple myelomaOncology lettersJuly 1, 2018Zhao W, Zhang X, Zang L, Zhao P, Chen Y, Wang X.then incubated at 4˚C overnight with the primary antibody. The proteins were probed by ILK (1:1,000, #sc‑20019, Santa Cruz Biotechnology), VEGF receptor 2 (1:1,000, #ab9530, Abcam), α‑SMA (1:1,000, #ab21027; Abcam)

(18) Correlation between PKB/Akt, GSK-3β expression and tubular epithelial-mesenchymal transition in renal allografts with chronic active antibody-mediated rejectionExperimental and therapeutic medicineMay 1, 2017Yan Q, Luo H, Wang B, Sui W, Zou G, Chen H, Zou H.1:100 dilution; Wuhan Boshide Co., Wuhan, China), mouse anti-human monoclonal ILK antibody (cat. no. SC-20019; 1:200 dilution; Santa Cruz Biotechnology, Inc., Dallas, TX, USA), rabbit anti-human TGF-β1 antibody

(19) YTH domain family 2 orchestrates epithelial-mesenchymal transition/proliferation dichotomy in pancreatic cancer cellsCell cycle (Georgetown, Tex.)January 1, 2017Chen J, Sun Y, Xu X, Wang D, He J, Zhou H, Lu Y, Zeng J, Du F, Gong A, et al.

(20) Cardiomyocyte progenitor cell mechanoresponse unrevealed: strain avoidance and mechanosome developmentIntegrative biology : quantitative biosciences from nano to macroSeptember 12, 2016Mauretti A, Bax NA, van Marion MH, Goumans MJ, Sahlgren C, Bouten CV.

Be the First to Write a Review!

ILK (65.1) Antibody

ILK (65.1) Antibody from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (43)

Reviews

ILK (65.1) Antibody from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map